{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:48:23Z","timestamp":1740134903107,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Lynch syndrome (LS), which is known as a hereditary cancer syndrome, is distinguished by microsatellite instability, represented by the altered number of repetitive sequences in the coding and\/or non-coding region. Immunohistochemical staining (IHC) of DNA mismatch repair (MMR) proteins (e.g., MLH1, MSH2, MSH6, and PMS2) has been recognized as an useful technique for screening of LS. Previous study has shown that the assessment of IHC, however, requires specific caution due to variable staining patterns even without germline mutations in <jats:italic>MMR<\/jats:italic> genes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 48-year-old man, who had been treated for anaplastic astrocytoma, was referred to our department for the precise examination of progressing anemia. Whole-body examination revealed two advanced carcinomas in descending colon and stomach. A hypo-vascular mass lesion was detected in liver as well. Pathological diagnosis (on surgical specimens) was poorly differentiated adenocarcinoma in descending colon, moderately differentiated tubular adenocarcinoma in stomach, and liver metastasis, which is possibly from colon. It was suspected that this case would be Turcot\u2019s syndrome-type-1 due to its specific family history having two cases of colon cancer within the second relatives. Pathogenic frameshift mutations in codon 618 of <jats:italic>MLH1<\/jats:italic> gene was identified. Immunohistochemical analyses (IHC) demonstrated complete loss of MLH1 immuno-expression as well as of PMS2 except for those in brain tumor. Although frameshift mutation was not found in <jats:italic>MSH6<\/jats:italic> gene, histological expression of MSH6 was patchy in primary colon carcinoma and was completely lost in the metastatic site in liver. MSH6 expression in gastric carcinoma, a coincidental cancer in this case, was intact. An abnormal (C)8 region was identified by the cloned PCR of colon and liver tumors but not from gastric cancer. Frameshift mutation in a (C)8 tract in exon 5 of the <jats:italic>MSH6<\/jats:italic> gene was also detected in liver metastasis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This case supports a plausible mechanism, proposed by a previous literature, for the reduced expression of MSH6 in a somatic mutation manner, which might preferentially happen in colon cancer rather than in stomach carcinoma in MLH1\/PMS2-deficient type of Turcot\u2019s syndrome type 1.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12881-020-01079-x","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T08:36:50Z","timestamp":1593592610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of Turcot\u2019s syndrome type 1 with loss of immunoexpression of MSH6 in colon cancer and liver metastasis due to secondary somatic mutation in coding mononucleotide (C)8 tract: a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Shintaro","family":"Akabane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0462-6177","authenticated-orcid":false,"given":"Takao","family":"Hinoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiwamu","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Sada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Onoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Tazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Hadano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Misumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruna","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Taniyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Kuraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"issue":"8","key":"1079_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2176\/nmc.44.124","volume":"44","author":"H Okamoto","year":"2004","unstructured":"Okamoto H, Mineta T, Nakahara Y, Ichinose M, Shiraishi T, Tabuchi K. Molecular analysis of astrocytoma associated with Turcot syndrome type 1--case report. Neurol Med Chir (Tokyo). 2004;44(8):124.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"1079_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/BF02560221","volume":"28","author":"H Itoh","year":"1985","unstructured":"Itoh H, Ohsato K. Turcot syndrome and its characteristic colonic manifestations. Dis Colon Rectum. 1985;28:399\u2013402.","journal-title":"Dis Colon Rectum"},{"key":"1079_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2353\/jmoldx.2008.080031","volume":"10","author":"J Shia","year":"2008","unstructured":"Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: part I. the utility of immunohistochemistry. J Mol Diagnostics. 2008;10:293\u2013300.","journal-title":"J Mol Diagnostics"},{"key":"1079_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10689-013-9615-1","volume":"12","author":"E Barrow","year":"2013","unstructured":"Barrow E, Hill J, Gareth ED. Cancer risk in lynch syndrome. Familial Cancer. 2013;12:229\u201340.","journal-title":"Familial Cancer"},{"key":"1079_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/256063","volume":"2011","author":"K Masuda","year":"2011","unstructured":"Masuda K, Banno K, Yanokura M, et al. Relationship between DNA mismatch repair deficiency and endometrial Cancer. Mol Biol Int. 2011;2011:1\u20136.","journal-title":"Mol Biol Int"},{"key":"1079_CR6","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1200\/JCO.2003.04.060","volume":"21","author":"P Peltom\u00e4ki","year":"2003","unstructured":"Peltom\u00e4ki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol. 2003;21:1174\u20139.","journal-title":"J Clin Oncol"},{"key":"1079_CR7","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","volume":"138","author":"CR Boland","year":"2010","unstructured":"Boland CR, Goel A. Microsatellite Instability in Colorectal Cancer. Gastroenterology. 2010;138:2073\u201387 e3.","journal-title":"Gastroenterology"},{"key":"1079_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/modpathol.2012.138","volume":"26","author":"J Shia","year":"2014","unstructured":"Shia J, Zhang L, Shike M, et al. Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1\/PMS2 deficiency. Mod Pathol. 2014;26:131\u20138.","journal-title":"Mod Pathol"},{"key":"1079_CR9","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1056\/NEJM199503303321302","volume":"332","author":"SR Hamilton","year":"2014","unstructured":"Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, et al. The molecular basis of turcot\u2019s syndrome. N Engl J Med. 2014;332:839\u201347.","journal-title":"N Engl J Med"},{"key":"1079_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1155\/2004\/305058","volume":"20","author":"PVH Peltom\u00e4ki","year":"2004","unstructured":"Peltom\u00e4ki PVH. Mutations associated with HNPCC predisposition \u2013 update of ICG-HNPCC \/ INSiGHT mutation database. Dis Markers. 2004;20:269\u201376.","journal-title":"Dis Markers"},{"key":"1079_CR11","first-page":"1","volume":"0","author":"K Tanakaya","year":"2018","unstructured":"Tanakaya K. Current clinical topics of lynch syndrome. Int J Clin Oncol. 2018;0:1\u20137.","journal-title":"Int J Clin Oncol"},{"key":"1079_CR12","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0002-9440(10)63074-X","volume":"159","author":"T Hinoi","year":"2001","unstructured":"Hinoi T, Tani M, Lucas PC, et al. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the Colon. Am J Pathol. 2001;159:2239\u201348.","journal-title":"Am J Pathol"},{"key":"1079_CR13","doi-asserted-by":"publisher","first-page":"44608","DOI":"10.1074\/jbc.M307435200","volume":"278","author":"T Hinoi","year":"2003","unstructured":"Hinoi T, Loda M, Fearon ER. Silencing of CDX2 expression in Colon Cancer via a dominant repression pathway. J Biol Chem. 2003;278:44608\u201316.","journal-title":"J Biol Chem"},{"key":"1079_CR14","first-page":"2447","volume":"62","author":"A Duval","year":"2002","unstructured":"Duval A, Hamelin R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res. 2002;62:2447\u201354.","journal-title":"Cancer Res"},{"key":"1079_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0378-1119(01)00517-0","volume":"272","author":"N Ohmiya","year":"2001","unstructured":"Ohmiya N, Matsumoto S, Yamamoto H, Baranovskaya S, Malkhosyan SR, Perucho M. Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype. Gene. 2001;272:301\u201313.","journal-title":"Gene."},{"key":"1079_CR16","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1097\/PAS.0000000000000459","volume":"39","author":"A Felix","year":"2015","unstructured":"Felix A, Rosa E. Heterogenous MSH6 loss is a result of microsatellite instability within MSH6 and occurs in sporadic and hereditary colorectal and endometrial carcinomas. Am J Surg Pathol. 2015;39:1370\u20136.","journal-title":"Am J Surg Pathol"},{"key":"1079_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000079488","volume":"66","author":"R Martinez","year":"2004","unstructured":"Martinez R, Schackert HK, Plaschke J, Baretton G, Appelt H, Schackert G. Molecular mechanisms associated with chromosomal and microsatellite instability in sporadic glioblastoma multiforme. Oncology. 2004;66:395\u2013403.","journal-title":"Oncology."},{"key":"1079_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1056\/NEJMoa022289","volume":"349","author":"CM Ribic","year":"2003","unstructured":"Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for Colon Cancer. N Engl J Med. 2003;349:247\u201357.","journal-title":"N Engl J Med"},{"key":"1079_CR19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3:330\u20138.","journal-title":"Nat Rev Cancer"},{"key":"1079_CR20","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1200\/JCO.2015.63.4238","volume":"33","author":"T Andr\u00e9","year":"2015","unstructured":"Andr\u00e9 T, De Gramont A, Vernerey D, et al. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study. J Clin Oncol. 2015;33:4176\u201387.","journal-title":"J Clin Oncol"},{"key":"1079_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamaoncol.2017.2899","volume":"4","author":"A Zaanan","year":"2018","unstructured":"Zaanan A, Shi Q, Taieb J, et al. Role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy a pooled analysis from 2 randomized clinical trials. JAMA Oncol. 2018;4:379\u201383.","journal-title":"JAMA Oncol"},{"key":"1079_CR22","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","volume":"28","author":"DJ Sargent","year":"2010","unstructured":"Sargent DJ, Marsoni S, Monges G, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28:3219\u201326.","journal-title":"J Clin Oncol"},{"key":"1079_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"6733","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Laveet KA, Lu S, Kemberling H, Wilt C, Luber BS, Wong F, Nilofer S, et al. Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;6733:409\u201313.","journal-title":"Science."}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-020-01079-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12881-020-01079-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-020-01079-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T23:25:12Z","timestamp":1625181912000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-020-01079-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1079"],"URL":"https:\/\/doi.org\/10.1186\/s12881-020-01079-x","relation":{},"ISSN":["1471-2350"],"issn-type":[{"type":"electronic","value":"1471-2350"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"assertion":[{"value":"24 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All research was approved by the Ethics Committees of Kure Medical Center and Chugoku Cancer Center. All participants have provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of identifying images or other personal or clinical details was obtained from all of the participants. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}